Table 2. Blood and brain concentrations of fluorene and monohydroxylated metabolites.
Variable | Freely-moving rats | Restrained controls | 1.5 ppb | 150 ppb | ANOVA | |
F(3, 20) | p | |||||
Blood (ng/mL) | ||||||
Fluorene | 72.6±11.3 | 70.8±22.5 | 56.4±22.3 | 35.6±8.9 | 0.904 | n.s. |
9-OH fluorene | 0.98±0.13 | 1.42±0.21 | 0.75±0.21 | 3.80±0.46 * | 27.007 | <0.01 |
3-OH fluorene | n.d. | n.d. | < LOQ | 2.48±0.57 ** | 22.335 | <0.01 |
2-OH fluorene | n.d. | n.d. | 1.10±0.15 ** | 105.0±18.4 ** | 39.095 | <0.01 |
Brain (ng/g tissue) | ||||||
Fluorene | 34.121±2.38 | 31.97±2.28 | 21.13±3.68 ** | 19.82±0.31 ** | 8.763 | <0.01 |
9-OH fluorene | 0.68±0.06 | 0.76±0.26 | 0.54±0.02 | 1.35±0.23 * | 4.116 | <0.05 |
3-OH fluorene | n.d. | n.d. | n.d. | n.d. | – | – |
2-OH fluorene | n.d. | n.d. | < LOQ | 0.55±0.09 ** | 24.417 | <0.01 |
Results are expressed as mean ± S.E.M. of n = 6 rats/group. Dunnett's t-test was used for multiple comparisons. ** p<0.01, * p<0.05, statistical significant differences from restrained controls. Abbreviations: n.d., non detectable, n.s., non significant, LOQ, limit of quantification.